Georgian

Georgian (formerly Georgian Partners) is a Toronto-based growth-stage investment firm with a distinctive thesis built around applied AI for B2B software businesses, with a dedicated technical team that helps portfolio companies operationalize machine learning, trust, and data products. The georgian.io platform combines capital with embedded technical expertise (the Georgian Stack), making the firm one of the more credibly differentiated growth investors for AI-native businesses. For healthcare AI founders, Georgian is a strong match for revenue-stage B2B healthcare software businesses where AI is a core product capability rather than a marketing layer: clinical decision support platforms with substantial ARR, healthcare workflow automation companies, payer and provider AI tools, and healthcare data infrastructure businesses. Plausible check sizes run 10M to 50M at growth stage, with the firm leading or co-leading Series B and C rounds. Founders at seed or Series A should look elsewhere; Georgian invests at growth stage. Founders building deep biotech, medical devices, or research-stage AI should also pass; the firm’s thesis is B2B software, not regulated life sciences. Entry path is warm introduction through B2B SaaS founders in their portfolio, AI operator networks, or technical advisors. The firm responds to credible inbound from revenue-stage AI businesses. Diligence will be technically rigorous and metric-heavy: expect deep engagement on AI architecture, data strategy, and trust and compliance posture, alongside standard growth equity diligence on retention, expansion, and unit economics. The value-add is real and differentiated: the Georgian Stack helps portfolio companies build production AI systems, and the firm’s brand attracts strong syndicate partners. Bring AI architecture detail and substantive ARR to the first meeting.